Jeffrey B. Mirviss Boston Scientific Corp (BSX) insider trading activity

Jeffrey B. Mirviss is EVP&Pres, Periph Intervent of BOSTON SCIENTIFIC CORP. Currently has a direct ownership of 28,022 shares of BSX, which is worth approximately $2.56 Million. The most recent transaction as insider was on Apr 28, 2021, when has been sold 48,439 shares (Common Stock) at a price of $7.39 per share, resulting in proceeds of $357,964. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 28K

0% 3M change

50.48% 12M change

Total Value Held $2.56 Million

Jeffrey B. Mirviss Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Apr 28 2021	BUY Exercise of conversion of derivative security	$357,964 $7.39 p/Share	48,439 Added 20.52%	187,597 Common Stock
Apr 15 2021	SELL Open market or private sale	$1,151,637 $40.95 p/Share	28,123 Reduced 16.81%	139,158 Common Stock
Apr 15 2021	BUY Exercise of conversion of derivative security	$176,612 $6.28 p/Share	28,123 Added 14.39%	167,281 Common Stock
Feb 28 2021	SELL Payment of exercise price or tax liability	$36,027 $38.78 p/Share	929 Reduced 0.66%	139,158 Common Stock
Feb 28 2021	BUY Exercise of conversion of derivative security	-	2,037 Added 1.43%	140,087 Common Stock
Feb 22 2021	SELL Payment of exercise price or tax liability	$41,474 $39.2 p/Share	1,058 Reduced 0.76%	138,050 Common Stock
Feb 22 2021	BUY Exercise of conversion of derivative security	-	2,318 Added 1.64%	139,108 Common Stock
Feb 21 2021	SELL Payment of exercise price or tax liability	$36,851 $38.03 p/Share	969 Reduced 0.7%	136,790 Common Stock
Feb 21 2021	BUY Exercise of conversion of derivative security	-	2,804 Added 1.99%	137,759 Common Stock
Feb 18 2021	SELL Payment of exercise price or tax liability	$32,342 $37.52 p/Share	862 Reduced 0.63%	134,955 Common Stock
Feb 18 2021	BUY Exercise of conversion of derivative security	-	2,816 Added 2.03%	135,817 Common Stock
Feb 15 2021	SELL Payment of exercise price or tax liability	$23,879 $38.39 p/Share	622 Reduced 0.47%	133,001 Common Stock
Feb 15 2021	BUY Exercise of conversion of derivative security	-	2,030 Added 1.5%	133,623 Common Stock
Feb 12 2021	SELL Open market or private sale	$212,892 $38.75 p/Share	5,494 Reduced 4.01%	131,593 Common Stock
Feb 10 2021	SELL Payment of exercise price or tax liability	$94,134 $38.85 p/Share	2,423 Reduced 1.74%	137,087 Common Stock
Feb 10 2021	BUY Grant, award, or other acquisition	-	7,917 Added 5.37%	139,510 Common Stock
Jan 05 2021	SELL Open market or private sale	$286,293 $35.31 p/Share	8,108 Reduced 5.8%	131,636 Common Stock
Jan 01 2021	SELL Payment of exercise price or tax liability	$138,731 $35.95 p/Share	3,859 Reduced 2.69%	139,744 Common Stock
Jan 01 2021	BUY Exercise of conversion of derivative security	-	11,967 Added 7.69%	143,603 Common Stock
Dec 17 2020	SELL Bona fide gift	-	150 Reduced 0.11%	131,636 Common Stock
Dec 11 2020	SELL Bona fide gift	-	50 Reduced 0.04%	131,786 Common Stock
Dec 03 2020	SELL Payment of exercise price or tax liability	$10,008 $33.81 p/Share	296 Reduced 0.22%	131,836 Common Stock
Dec 03 2020	BUY Exercise of conversion of derivative security	-	649 Added 0.49%	132,132 Common Stock
Dec 01 2020	SELL Open market or private sale	$1,561,961 $33.53 p/Share	46,584 Reduced 26.16%	131,483 Common Stock
Dec 01 2020	BUY Exercise of conversion of derivative security	$333,541 $7.16 p/Share	46,584 Added 20.74%	178,067 Common Stock

JBM

Jeffrey B. Mirviss

EVP&Pres, Periph Intervent

Marlborough, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BSX shares.

Notify only if

Value

Insider Trading

Get notified when an Boston Scientific Corp insider buys or sells BSX shares.

Notify only if

Operation

Value

Type

News

Receive news related to BOSTON SCIENTIFIC CORP

Track Activities on BSX

Account